EUVIMEDEUVIMED entdecken
Crossref

Multifunctional Liposome Delivery System Based on Ursodeoxycholic Acid Sodium for the Encapsulation of Silibinin and Combined Treatment of Alcoholic Liver Injury

Yulu Wang, Minghao Yuan, Sihui Li, Jiamei Tang, Yan Wan, Xue Liang, Yiping Guo iD, Li Guo iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Yulu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611100, China. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Liposomes, Silybin, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Chengdu University of Traditional Chinese Medicine, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol liver disease (ALD) is a chronic liver disorder resulting from long-term heavy alcohol consumption. The pathogenesis of ALD is multifactorial, and existing therapeutic agents primarily target specific aspects of the disease while presenting significant side effects, including drug-induced liver injury and hepatobiliary disease. Silibinin (SLB) has attracted widespread attention for its hepatoprotective effects and favorable safety profile. However, inherent limitations associated with SLB, such as poor solubility and bioavailability, have significantly limited its clinical application. Drug delivery systems, including liposomes, offer promising potential for the delivery of hydrophobic drugs. However, the selection of an appropriate delivery vehicle requires optimization. Ursodeoxycholic acid sodium (UAS) serves as a promising alternative to cholesterol in liposomal formulations, offering a potential strategy to mitigate the health risks associated with cholesterol. In this study, UAS was employed as the liposomal membrane material to prepare a UAS liposome loaded with SLB (SUL), and its efficacy and mechanism of action in alcoholic-induced liver injury were subsequently evaluated. The experimental results demonstrated that SUL exhibited a uniform particle size distribution, good stability, and an effective release profile in vitro. Following oral administration, SUL effectively inhibited alcohol-induced liver damage, oxidative stress, and fat accumulation. In addition, SUL regulated the expression of the kelch-1ike ECH- associated protein l (Keap1), nuclear factor erythroid 2-related factor 2 (Nrf2), and heme oxygenase 1 (HO-1) proteins, thereby exerting antioxidative stress effects. Furthermore, it also modulated apoptosis-related factors, including B-cell lymphoma-2 (Bcl-2), BCL-2-associated X (Bax), cysteinyl aspartate specific proteinase-3 (Caspase-3), and cleaved caspase-3, to mitigate hepatocyte apoptosis. In summary, SUL demonstrates enhanced therapeutic efficacy against ALD, offering a novel approach for the clinical application of SLB in the prevention and treatment of ALD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ursodeoxycholic AcidLiposomesSilybinDrug Delivery SystemsLiver Diseases, AlcoholicAnimalsHumansApoptosisMaleLiverOxidative StressRatsMice

Stichwörter der Autor:innen

alcohol-associated liver diseaseantioxidative stressliposomessilibininursodeoxycholic acid sodium

Substanzen

Ursodeoxycholic AcidLiposomesSilybin

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611100, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611100, China.

ORCID-Profile: Yiping Guo, Li Guo

Förderung

  • Chengdu University of Traditional Chinese Medicine
  • Science and Technology Department of Sichuan Province

Zitieren

APA

Wang, Y., Yuan, M., Li, S., Tang, J., Wan, Y., Liang, X., Guo, Y., & Guo, L. (2025). Multifunctional Liposome Delivery System Based on Ursodeoxycholic Acid Sodium for the Encapsulation of Silibinin and Combined Treatment of Alcoholic Liver Injury. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01197

Vancouver

Wang Y, Yuan M, Li S, Tang J, Wan Y, Liang X, et al. Multifunctional Liposome Delivery System Based on Ursodeoxycholic Acid Sodium for the Encapsulation of Silibinin and Combined Treatment of Alcoholic Liver Injury. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01197

BibTeX
@article{Wang2025,
  author = {Wang, Yulu and Yuan, Minghao and Li, Sihui and Tang, Jiamei and Wan, Yan and Liang, Xue and Guo, Yiping and Guo, Li},
  title = {Multifunctional Liposome Delivery System Based on Ursodeoxycholic Acid Sodium for the Encapsulation of Silibinin and Combined Treatment of Alcoholic Liver Injury},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01197}
}
Kostenlos starten →